Topic: MS

Treatment initiation with ofatumumab: ACTRIMS Forum 2026 highlights

February 19, 2026  

ACTRIMS FORUM 2026 HIGHLIGHTS – TUESDAY, FEBRUARY 10, 2026

February 10, 2026  

ACTRIMS FORUM 2026 HIGHLIGHTS – MONDAY, FEBRUARY 9, 2026

February 9, 2026  

ACTRIMS Forum 2026 survey

February 3, 2026  

PRL detected in optic chiasm

January 30, 2026  

BTK inhibitors – a look ahead

January 20, 2026  

High-efficacy DMTs for MS: the year in review

December 1, 2025  

Ocrelizumab use throughout the MS clinical course: highlights from ECTRIMS 2025

October 15, 2025  

Early use and long-term safety of ofatumumab: highlights from ECTRIMS 2025

October 7, 2025  

ECTRIMS 2025 HIGHLIGHTS – SATURDAY, SEPTEMBER 27, 2025

September 27, 2025